BMS 493

Retinoid pathway activator; Activates pan-retinoic acid receptor

BMS 493

Retinoid pathway activator; Activates pan-retinoic acid receptor

From: 64 USD
Catalog #
(Select a product)
Retinoid pathway activator; Activates pan-retinoic acid receptor
Add to Wish List

Overview

BMS 493 is an inverse agonist of the pan-retinoic acid receptors (RARs). RARs are ligand-dependent transcription factors that regulate gene networks that control cell growth, differentiation, survival, and death (Germain et al.). BMS 493 has been shown to increase nuclear receptor co-repressor (NCoR) interaction with RARs (Germain et al.; Rinkevich et al.).


DIFFERENTIATION
· Affects development of bronchial tubule formation in mice (Chazaud et al.).

· Inhibits activation of immature dendritic cells (Geissmann et al.).

CANCER RESEARCH

· Inhibits differentiation of leukemic blasts (Kamashev et al.).
Cell Type
Airway Cells, Cancer Cells and Cell Lines, Hematopoietic Stem and Progenitor Cells, Monocytes
Species
Human, Mouse, Non-Human Primate, Other, Rat
Application
Differentiation
Area of Interest
Cancer, Disease Modeling, Immunology, Stem Cell Biology
CAS Number
215030-90-3
Chemical Formula
C₂₉H₂₄O₂
Purity
≥ 98%
Pathway
Retinoid

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Product Name
BMS 493
Catalog #
73972, 73974
Lot #
All
Language
English
Document Type
Safety Data Sheet
Product Name
BMS 493
Catalog #
73972, 73974
Lot #
All
Language
English

Resources and Publications

Publications (1)

Retinoic Acid Informs the Positional Identity of Frontonasal Neural Crest Cells Through Alx Family of Transcription Factors. S. Wu et al. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2026 Jun

Abstract

Cranial neural crest cells (CNCCs) give rise to the majority of the skeletal elements of the face. The precise morphogenesis of the face relies on highly coordinated actions of CNCCs, requiring each CNCC to obtain correct positional identity. As a diffusive signaling molecule, retinoic acid (RA) is known to regulate the positional identities along the anterior-posterior axis of the developing hindbrain by activating the Hox family of transcription factors. However, whether RA also has a direct role in regulating the positional identities of Hox-negative CNCCs, which give rise to the skeletal framework of the face, was unclear. In this study, we show that RA acts as a local environmental cue that patterns the Hox-negative CNCCs by activating the Alx family of transcription factors. We observed midfacial dysplasia and midline facial clefting in chick embryos after blocking RA signaling with an inverse pan-RAR agonist. Gene expression analysis revealed that this morphological defect is associated with the transformation of frontonasal neural crest identity toward a first pharyngeal arch (PA1)-like identity, a patterning defect that was also observed in Alx1 and Alx4 compound mutant mouse embryos. We further showed that both Alx1 and Alx4 are regulated by RA through cell-autonomous RA receptor (RAR) signaling. Mechanistically, RA signaling regulates Alx1 through an evolutionarily conserved distal enhancer located upstream of Alx1 within the intronic region of the gene Lrriq1, whereas the RA-responsiveness of Alx4 is conferred by its promoter. These findings establish a mechanistic linkage between RA signaling and Alx genes and provide novel insights into the craniofacial defects associated with disrupted RA signaling.